Strumento inattivo

Azioni Rennova Health Inc Nasdaq

Azioni

Durata

Periodo

Stile

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17/07/20
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08/07/20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29/06/20
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16/06/20

Dirigenti	Titolo	Età	Da
Darrell Peterson CEO	Chief Executive Officer	65	14/05/23
Gerard Dab CHM	Chairman	75	14/05/23
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Amministratori	Titolo	Età	Da
Gerard Dab CHM	Chairman	75	14/05/23
Sharon Hollis CEO	Chief Executive Officer	47	01/07/11
Francisco Roca BRD	Director/Board Member	58	14/05/23

Settore

	Variaz. 1 gen.	Capi.
SONIC HEALTHCARE LIMITED	-17,89%	8,25 Mrd
RADNET, INC.	+39,20%	3,57 Mrd
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39,11%	2,46 Mrd
SYNLAB AG	-8,06%	2,46 Mrd
DR. LAL PATHLABS LIMITED	-7,35%	2,38 Mrd
NEOGENOMICS, INC.	-12,61%	1,81 Mrd
FLEURY S.A.	-19,01%	1,55 Mrd
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40,66%	1,21 Mrd
METROPOLIS HEALTHCARE LIMITED	+7,56%	1,11 Mrd